Trial Profile
A Pilot Study of use of dexmedetomidine for delirium control by reduce the serum concentration of brain-derived neurotrophic factor (BDNF), neuron-specific enolase(NSE) and S100B in patients undergoing polytrauma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary) ; Midazolam; Propofol
- Indications Delirium
- Focus Adverse reactions; Therapeutic Use
- 28 Apr 2016 New trial record